FDA makes some strides in eas­ing US can­cer drug sup­ply short­ages by work­ing with man­u­fac­tur­ers

The FDA has boost­ed its col­lab­o­ra­tion chan­nels with can­cer drug man­u­fac­tur­ers and health­care providers to im­prove the US sup­ply of cis­platin, car­bo­platin and methotrex­ate, ac­cord­ing to a White House press re­lease from Tues­day.

The cis­platin short­age first ap­peared in Feb­ru­ary, and car­bo­platin ap­peared in May. Methotrex­ate in­jec­tions en­tered the short­age list in March, and its tablet form en­tered in Ju­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER